quinidine has been researched along with dextromethorphan - quinidine combination in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (13.33) | 29.6817 |
| 2010's | 26 (86.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appel, SH; Berg, JE; Bradley, WG; Brooks, BR; Olney, RK; Pope, LE; Smith, RA; Thisted, RA | 1 |
| Hauser, SL; Johnston, SC | 1 |
| Rosen, H | 1 |
| Drmić, S; Mimica, N; Presecki, P | 1 |
| Olney, N; Rosen, H | 1 |
| Garnock-Jones, KP | 1 |
| Pioro, EP | 1 |
| Hepner, A; Pope, LE; Shaibani, AI; Thisted, R | 1 |
| Stahl, SM | 2 |
| Casselman, J; Patatanian, E | 1 |
| Appel, SH; Formella, AE; Lomen-Hoerth, C; Pattee, GL; Pope, LE; Wymer, JP | 1 |
| Ferrara, JM | 1 |
| Deeks, ED; Yang, LP | 1 |
| Antonsdottir, IM; Keltz, M; Porsteinsson, AP; Smith, J | 1 |
| Cutler, AJ; D'Amico, S; Davis, CS; Doody, RS; Ledon, F; Shin, P; Siffert, J; Yonan, C | 1 |
| Carroll, BT; Denysenko, L; Mitchell, JL; Turner, J | 1 |
| Garcia-Baran, D; Geers, M; Johnson, TM; Shen, J; Wagner, J | 1 |
| Alexander, DN; Cutler, AJ; D'Amico, S; Davis, CS; Doody, RS; Formella, AE; Hammond, FM; Ledon, F; Sauve, W; Shin, P; Siffert, J; Yonan, C; Zorowitz, RD | 1 |
| Crumpacker, DW | 1 |
| Garay, RP; Grossberg, GT | 1 |
| Reiman, AT; Schrader, JV; Wahler, RG | 1 |
| Sauvé, WM | 1 |
| Cudkowicz, M; Goslin, K; Macklin, EA; Meekins, G; Myers, K; Pattee, G; Pioro, E; Schoenfeld, D; Sirdofsky, M; Smith, R; Wymer, J; Yu, H | 1 |
| Charpeaud, T; Citrome, L; Correll, CU; Garay, RP; Hameg, A; Llorca, PM; Zarate, CA | 1 |
| Bell, JS; Chaiyakunapruk, N; Hilmer, SN; Kongpakwattana, K; Sawangjit, R; Tawankanjanachot, I | 1 |
| Calcagno, HE; Chen, Q; Shad, M | 1 |
| Allison, KM; Berry, JD; Cordella, C; Green, JR; Macklin, EA; Pattee, GL; Pioro, EP; Richburg, BD; Smith, RA | 1 |
| Fralick, M; Kesselheim, AS; Sacks, CA | 1 |
12 review(s) available for quinidine and dextromethorphan - quinidine combination
| Article | Year |
|---|---|
Dextromethorphan/quinidine sulfate for pseudobulbar affect.
Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Dextromethorphan; Drug Combinations; Humans; Pseudobulbar Palsy; Quinidine; Selective Serotonin Reuptake Inhibitors | 2008 |
AVP-923, a combination of dextromethorphan hydrobromide and quinidine sulfate for the treatment of pseudobulbar affect and neuropathic pain.
Topics: Animals; Clinical Trials as Topic; Dextromethorphan; Diabetic Neuropathies; Drug Combinations; Humans; Mood Disorders; Quinidine | 2010 |
Dextromethorphan/quinidine: in pseudobulbar affect.
Topics: Amyotrophic Lateral Sclerosis; Crying; Dextromethorphan; Drug Combinations; Emotions; Female; Humans; Laughter; Male; Mood Disorders; Multiple Sclerosis; Quinidine | 2011 |
Current concepts in the pharmacotherapy of pseudobulbar affect.
Topics: Antidepressive Agents; Crying; Dextromethorphan; Drug Combinations; Humans; Laughter; Mood Disorders; Off-Label Use; Quinidine | 2011 |
Dextromethorphan/quinidine for the treatment of pseudobulbar affect.
Topics: Clinical Trials as Topic; Crying; Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Humans; Laughter; Pseudobulbar Palsy; Quinidine; Receptors, sigma; Sigma-1 Receptor; Treatment Outcome | 2014 |
Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect.
Topics: Adult; Dextromethorphan; Drug Combinations; Humans; Mood Disorders; Nervous System Diseases; Quinidine | 2015 |
Advancements in the treatment of agitation in Alzheimer's disease.
Topics: Alzheimer Disease; Cannabinoid Receptor Agonists; Cannabinoids; Citalopram; Clinical Trials, Phase III as Topic; Dextromethorphan; Drug Combinations; Humans; Psychomotor Agitation; Quinidine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2015 |
Enhancing Approaches to the Identification and Management of Pseudobulbar Affect.
Topics: Affective Symptoms; Crying; Dextromethorphan; Drug Combinations; Female; Humans; Laughter; Middle Aged; Multiple Sclerosis; Neurotransmitter Agents; Quinidine | 2016 |
AVP-786 for the treatment of agitation in dementia of the Alzheimer's type.
Topics: Alzheimer Disease; Animals; Brain; Deuterium; Dextromethorphan; Drug Combinations; Humans; Psychomotor Agitation; Quinidine; Randomized Controlled Trials as Topic; Tissue Distribution; Treatment Outcome | 2017 |
Recognizing and treating pseudobulbar affect.
Topics: Dextromethorphan; Drug Combinations; Early Diagnosis; Excitatory Amino Acid Antagonists; Humans; Pseudobulbar Palsy; Quinidine | 2016 |
Investigational drugs in recent clinical trials for treatment-resistant depression.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resistant; Dextromethorphan; Drug Combinations; Drugs, Investigational; Humans; Quinidine | 2017 |
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.
Topics: Antipsychotic Agents; Dementia; Dextromethorphan; Drug Combinations; Humans; Network Meta-Analysis; Psychometrics; Psychomotor Agitation; Quinidine; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2018 |
5 trial(s) available for quinidine and dextromethorphan - quinidine combination
| Article | Year |
|---|---|
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Double-Blind Method; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pseudobulbar Palsy; Quinidine; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2004 |
Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Dextromethorphan; Diabetic Neuropathies; Double-Blind Method; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Placebos; Quinidine | 2012 |
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
Topics: Adolescent; Adult; Affective Symptoms; Aged; Aged, 80 and over; Cohort Studies; Crying; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Laughter; Male; Middle Aged; Pseudobulbar Palsy; Quinidine; Treatment Outcome; Young Adult | 2014 |
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
Topics: Aged; Brain Injuries, Traumatic; Dementia; Dextromethorphan; Drug Administration Schedule; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Pseudobulbar Palsy; Quinidine; Severity of Illness Index; Stroke; Treatment Outcome | 2016 |
Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Cross-Over Studies; Dextromethorphan; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Quinidine | 2017 |
13 other study(ies) available for quinidine and dextromethorphan - quinidine combination
| Article | Year |
|---|---|
Marketing and drug costs: who is laughing and crying?
Topics: Affective Symptoms; Dextromethorphan; Drug Combinations; Drug Costs; Drug Industry; Humans; Laughter; Marketing; Quinidine; Smiling | 2007 |
Involuntary emotional expression disorder in Alzheimer's disease - psychopharmacotherapy aspects.
Topics: Affective Symptoms; Alzheimer Disease; Clinical Trials as Topic; Combined Modality Therapy; Croatia; Crying; Dextromethorphan; Drug Approval; Drug Combinations; Expressed Emotion; Humans; Laughter; Psychotropic Drugs; Quinidine; United States | 2009 |
Dextromethorphan/quinidine (Nuedexta) for pseudobulbar affect.
Topics: Dextromethorphan; Drug Combinations; Drug Interactions; Humans; Pseudobulbar Palsy; Quinidine | 2011 |
Mechanism of action of dextromethorphan/quinidine:comparison with ketamine.
Topics: Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Humans; Ketamine; Mood Disorders; Quinidine | 2013 |
CRPS-related neurogenic edema responsive to dextromethorphan/quinidine.
Topics: Adult; Causalgia; Dextromethorphan; Drug Combinations; Edema; Female; Humans; Leg; Quinidine | 2014 |
An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Dementia, Vascular; Dextromethorphan; Diarrhea; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Frontotemporal Dementia; Headache; Humans; Lewy Body Disease; Male; Middle Aged; Pseudobulbar Palsy; Quinidine; Urinary Tract Infections | 2016 |
Dextromethorphan/quinidine withdrawal-emergent catatonia.
Topics: Aged; Catatonia; Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Humans; Male; Psychotic Disorders; Quinidine; Receptors, N-Methyl-D-Aspartate | 2016 |
Therapeutic Approach of a High Functioning Individual With Traumatic Brain Injury and Subsequent Emotional Volatility With Features of Pathological Laughter and Crying With Dextromethorphan/Quinidine.
Topics: Adult; Affective Symptoms; Brain Concussion; Brain Injuries; Crying; Dextromethorphan; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Laughter; Male; Quinidine; Stress Disorders, Post-Traumatic | 2016 |
Dextromethorphan-quinidine-responsive pseudobulbar affect (PBA): psychopharmacological model for wide-ranging disorders of emotional expression?
Topics: Dextromethorphan; Drug Combinations; Emotions; Excitatory Amino Acid Antagonists; Humans; Models, Theoretical; Pseudobulbar Palsy; Psychopharmacology; Quinidine; Receptors, Glutamate; Receptors, Serotonin; Receptors, sigma | 2016 |
Use of Compounded Dextromethorphan-Quinidine Suspension for Pseudobulbar Affect in Hospice Patients.
Topics: Aged, 80 and over; Crying; Dextromethorphan; Drug Combinations; Female; Hospice Care; Humans; Laughter; Male; Medical Audit; Pseudobulbar Palsy; Quinidine; Retrospective Studies; Treatment Outcome | 2017 |
Efficacy of Dextromethorphan/Quinidine for Patients With Psychosis-Related Aggression: A Retrospective Case Series.
Topics: Aged; Aggression; Dextromethorphan; Drug Combinations; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Impulsive Behavior; Male; Middle Aged; Outcome Assessment, Health Care; Psychotic Disorders; Quinidine; Retrospective Studies | 2018 |
Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Dextromethorphan; Drug Combinations; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Quinidine; Speech | 2018 |
Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect.
Topics: Aged; Amyotrophic Lateral Sclerosis; Dementia; Dextromethorphan; Drug Combinations; Excitatory Amino Acid Antagonists; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Pseudobulbar Palsy; Quinidine; United States; United States Food and Drug Administration | 2019 |